AIMS/HYPOTHESIS: The aim of this study was to examine the prevalence and nature of mutations in HNF4alpha/MODY1, GCK/MODY2 and HNF-1alpha/MODY3 genes in Czech subjects with clinical diagnosis of MODY. METHODS: We studied 61 unrelated index probands of Czech origin (28 males, 33 females) with a clinical diagnosis of MODY and 202 family members. The mean age of probands was 22.7+/-12.0 years (range, 6-62) and the mean age at the first recognition of hyperglycaemia was 14.7+/-6.0 years (range, 1-25). The promotor and coding regions inclusive intron exon boundaries of the HNF-4alpha, GCK and HNF-1alpha genes were examined by PCR-dHPLC (HNF-1alpha and GCK) and direct sequencing. RESULTS: We identified 20 different mutations in the HNF-4alpha, GCK and HNF-1alpha in 29 families (48% of all families studied), giving a relative prevalence of 5% of MODY1, 31% of MODY2 and 11.5% of MODY3 among the Czech kindred with MODY. Three of 3, 10 of 11 and 1 of 6 of the mutations identified in HNF-4alpha, GCK and HNF-1alpha respectively, were new. CONCLUSION/ INTERPRETATION: Of the families 48% carried mutations in the MODY1-3 genes and of the identified mutations 70% were new. In 52% of Czech families with clinical characteristics of MODY, no mutations were found in the analysed genes. This finding shows that the majority of MODY mutations in a central European population are local and that other MODY genes could be responsible for autosomal dominant transmission of diabetes mellitus.
AIMS/HYPOTHESIS: The aim of this study was to examine the prevalence and nature of mutations in HNF4alpha/MODY1, GCK/MODY2 and HNF-1alpha/MODY3 genes in Czech subjects with clinical diagnosis of MODY. METHODS: We studied 61 unrelated index probands of Czech origin (28 males, 33 females) with a clinical diagnosis of MODY and 202 family members. The mean age of probands was 22.7+/-12.0 years (range, 6-62) and the mean age at the first recognition of hyperglycaemia was 14.7+/-6.0 years (range, 1-25). The promotor and coding regions inclusive intron exon boundaries of the HNF-4alpha, GCK and HNF-1alpha genes were examined by PCR-dHPLC (HNF-1alpha and GCK) and direct sequencing. RESULTS: We identified 20 different mutations in the HNF-4alpha, GCK and HNF-1alpha in 29 families (48% of all families studied), giving a relative prevalence of 5% of MODY1, 31% of MODY2 and 11.5% of MODY3 among the Czech kindred with MODY. Three of 3, 10 of 11 and 1 of 6 of the mutations identified in HNF-4alpha, GCK and HNF-1alpha respectively, were new. CONCLUSION/ INTERPRETATION: Of the families 48% carried mutations in the MODY1-3 genes and of the identified mutations 70% were new. In 52% of Czech families with clinical characteristics of MODY, no mutations were found in the analysed genes. This finding shows that the majority of MODY mutations in a central European population are local and that other MODY genes could be responsible for autosomal dominant transmission of diabetes mellitus.
Authors: T M Frayling; J C Evans; M P Bulman; E Pearson; L Allen; K Owen; C Bingham; M Hannemann; M Shepherd; S Ellard; A T Hattersley Journal: Diabetes Date: 2001-02 Impact factor: 9.461
Authors: H Furuta; N Iwasaki; N Oda; Y Hinokio; Y Horikawa; K Yamagata; N Yano; J Sugahiro; M Ogata; H Ohgawara; Y Omori; Y Iwamoto; G I Bell Journal: Diabetes Date: 1997-10 Impact factor: 9.461
Authors: G Velho; H Blanché; M Vaxillaire; C Bellanné-Chantelot; V C Pardini; J Timsit; P Passa; I Deschamps; J J Robert; I T Weber; D Marotta; S J Pilkis; G M Lipkind; G I Bell; P Froguel Journal: Diabetologia Date: 1997-02 Impact factor: 10.122
Authors: A Costa; M Bescós; G Velho; J Chêvre; J Vidal; G Sesmilo; C Bellanné-Chantelot; P Froguel; R Casamitjana; F Rivera-Fillat; R Gomis; I Conget Journal: Eur J Endocrinol Date: 2000-04 Impact factor: 6.664
Authors: A M Møller; S A Urhammer; L T Dalgaard; R Reneland; L Berglund; T Hansen; J O Clausen; H Lithell; O Pedersen Journal: Diabetologia Date: 1997-08 Impact factor: 10.122
Authors: O Massa; F Meschi; A Cuesta-Munoz; A Caumo; F Cerutti; S Toni; V Cherubini; L Guazzarotti; N Sulli; F M Matschinsky; R Lorini; D Iafusco; F Barbetti Journal: Diabetologia Date: 2001-07 Impact factor: 10.122
Authors: N Shaat; E Karlsson; A Lernmark; S Ivarsson; K Lynch; H Parikh; P Almgren; K Berntorp; L Groop Journal: Diabetologia Date: 2006-04-26 Impact factor: 10.122
Authors: E R Pearson; S Pruhova; C J Tack; A Johansen; H A J Castleden; P J Lumb; A S Wierzbicki; P M Clark; J Lebl; O Pedersen; S Ellard; T Hansen; A T Hattersley Journal: Diabetologia Date: 2005-04-14 Impact factor: 10.122
Authors: Gitte Andersen; Lise Wegner; Christian Schack Rose; Jianxin Xie; Hao Zhu; Kevin Larade; Anders Johansen; Jakob Ek; Jeannet Lauenborg; Thomas Drivsholm; Knut Borch-Johnsen; Peter Damm; Torben Hansen; H Franklin Bunn; Oluf Pedersen Journal: Diabetes Date: 2004-11 Impact factor: 9.461
Authors: E Feigerlová; S Pruhová; L Dittertová; J Lebl; D Pinterová; K Kolostová; M Cerná; O Pedersen; T Hansen Journal: Eur J Pediatr Date: 2006-04-07 Impact factor: 3.183
Authors: Jacklyn N Hellwege; Pamela J Hicks; Nicholette D Palmer; Maggie C Y Ng; Barry I Freedman; Donald W Bowden Journal: J Diabetes Metab Date: 2011-10-20